Evaluation of serum procollagen C-proteinase enhancer 1 level as a fibrosis marker in patients with chronic hepatitis B

Gokce, Onur; Ozenirler, Seren; Yucel, Aysegul; Oruklu, Nihan; Esendagli, Guldal; KARAHAN, SEVİLAY

doi:10.1097/meg.0000000000001123

Evaluation of serum procollagen C-proteinase enhancer 1 level as a fibrosis marker in patients with chronic hepatitis B

Atıf İçin Kopyala

Gokce O., Ozenirler S., Yucel A. A., Oruklu N., Esendagli G. Y., KARAHAN S.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, cilt.30, sa.8, ss.918-924, 2018 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 30 Sayı: 8
Basım Tarihi: 2018
Doi Numarası: 10.1097/meg.0000000000001123
Dergi Adı: EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.918-924
Hacettepe Üniversitesi Adresli: Evet

Özet

Aim Although liver biopsy has long been considered the gold standard for staging fibrosis, because of the disadvantages and risks of biopsy, several noninvasive processes such as serum biomarkers have been introduced for the assessment of liver fibrosis. The aim of this study was to assess the diagnostic value of serum procollagen C-proteinase enhancer 1 (PCPE-1) as a noninvasive fibrosis marker in treatment-naive chronic hepatitis B patients.